{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:53Z","timestamp":1786119593535,"version":"build-2736575974"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12,1]]},"DOI":"10.1097\/qai.0b013e3181f9c10b","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T01:48:55Z","timestamp":1288662535000},"page":"S32-S36","source":"Crossref","is-referenced-by-count":83,"title":["Drug Treatment as HIV Prevention: A Research Update"],"prefix":"10.1097","volume":"55","author":[{"given":"David S","family":"Metzger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E","family":"Woody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210131","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM198112103052402","article-title":"An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.","volume":"305","author":"Masur","year":"1981","journal-title":"N Engl J Med"},{"key":"R2-7-20210131","first-page":"206","article-title":"Intravenous drug users and the acquired immune deficiency syndrome.","volume":"99","author":"Ginzburg","year":"1984","journal-title":"Public Health Rep"},{"issue":"Suppl 2","key":"R3-7-20210131","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1097\/QAI.0b013e3181baf128","article-title":"Measuring the impact of the global response to the AIDS epidemic: challenges and future directions.","volume":"52","author":"Mahy","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-7-20210131","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/COH.0b013e32832c06db","article-title":"Global epidemiology of HIV.","volume":"4","author":"Kilmarx","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"R6-7-20210131","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10461-005-9014-1","article-title":"Condom attitudes and behaviors among injection drug users participating in California syringe exchange programs.","volume":"9","author":"Bogart","year":"2005","journal-title":"AIDS Behav"},{"key":"R7-7-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.olq.0000148294.83012.d0","article-title":"Sexual risk among injection drug users recruited from syringe exchange programs in California.","volume":"32","author":"Bogart","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R8-7-20210131","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11524-007-9213-3","article-title":"Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis.","volume":"84","author":"Bluthenthal","year":"2007","journal-title":"J Urban Health"},{"key":"R9-7-20210131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00042560-200105010-00015","article-title":"Substance use among men who have sex with men: comparison with a national household survey.","volume":"27","author":"Woody","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-7-20210131","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2105\/AJPH.93.6.933","article-title":"An individually tailored intervention for HIV prevention: baseline data from the EXPLORE study.","volume":"93","author":"Chesney","year":"2003","journal-title":"Am J Public Health"},{"key":"R11-7-20210131","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/OLQ.0b013e3181a9cc41","article-title":"Prediction of HIV acquisition among men who have sex with men.","volume":"36","author":"Menza","year":"2009","journal-title":"Sex Transmit Dis"},{"key":"R12-7-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(04)16588-4","article-title":"Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study.","volume":"364","author":"Koblin","year":"2004","journal-title":"Lancet"},{"key":"R13-7-20210131","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.aids.0000216374.61442.55","article-title":"Risk factors for HIV infection among men who have sex with men.","volume":"20","author":"Koblin","year":"2006","journal-title":"AIDS"},{"key":"R14-7-20210131","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1360-0443.2008.02249.x","article-title":"Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV\/AIDS.","volume":"103","author":"Lawrinson","year":"2008","journal-title":"Addiction"},{"key":"R15-7-20210131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1300\/J069v17n04_08","article-title":"HIV\/AIDS and drug abuse: epidemiology and prevention.","volume":"17","author":"Haverkos","year":"1998","journal-title":"J Addict Dis"},{"key":"R16-7-20210131","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3109\/10826088509047770","article-title":"Drug-abuse treatment process-a review of the literature.","volume":"20","author":"Allison","year":"1985","journal-title":"Int J Addict"},{"key":"R17-7-20210131","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2307\/2137033","article-title":"Reducing the risk of aids through methadone-maintenance treatment.","volume":"29","author":"Ball","year":"1988","journal-title":"J Health Soc Behav"},{"key":"R18-7-20210131","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11606-006-0258-x","article-title":"Methadone treatment of injecting opioid users for prevention of HIV infection.","volume":"21","author":"Gowing","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"Suppl","key":"R19-7-20210131","first-page":"107","article-title":"Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.","volume":"113","author":"Hartel","year":"1998","journal-title":"Public Health Rep"},{"key":"R20-7-20210131","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jsat.2007.07.002","article-title":"Impact of methadone on drug use and risky sex in China.","volume":"34","author":"Qian","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"R21-7-20210131","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/10826089509048753","article-title":"Methadone-maintenance and the likelihood of risky needle-sharing.","volume":"30","author":"Caplehorn","year":"1995","journal-title":"Int J Addict"},{"key":"R22-7-20210131","first-page":"1049","article-title":"Human-immunodeficiency-virus seroconversion among intravenous-drug-users in-of-treatment and out-of-treatment-an 18-month prospective follow-up.","volume":"6","author":"Metzger","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-7-20210131","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1001\/jama.1993.03500150065028","article-title":"The effects of psychosocial services in substance-abuse treatment.","volume":"269","author":"McLellan","year":"1993","journal-title":"JAMA"},{"key":"R24-7-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1176\/ajp.156.1.27","article-title":"Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.","volume":"156","author":"Avants","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R25-7-20210131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0740-5472(03)00159-4","article-title":"Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.","volume":"26","author":"Avants","year":"2004","journal-title":"J Subst Abuse Treat"},{"key":"R26-7-20210131","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0740-5472(03)00029-1","article-title":"Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users.","volume":"24","author":"Wong","year":"2003","journal-title":"J Subst Abuse Treat"},{"key":"R27-7-20210131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1037\/0893-164X.11.4.261","article-title":"Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS).","volume":"11","author":"Hubbard","year":"1997","journal-title":"Psychol Addict Behav"},{"key":"R28-7-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0376-8716(96)01257-4","article-title":"Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users.","volume":"42","author":"Booth","year":"1996","journal-title":"Drug Alcohol Depend"},{"key":"R29-7-20210131","first-page":"77","article-title":"Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study.","volume":"14","author":"Gossop","year":"2002","journal-title":"AIDS Care-Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"key":"R30-7-20210131","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1300\/J069v17n04_06","article-title":"Does intensive outpatient cocaine treatment reduce AIDS risky behaviors?","volume":"17","author":"Gottheil","year":"1998","journal-title":"J Addict Dis"},{"key":"R31-7-20210131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF02386744","article-title":"Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.","volume":"77","author":"Thiede","year":"2000","journal-title":"J Urban Health"},{"key":"R32-7-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.1990.00390130099014","article-title":"Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone-maintenance patients.","volume":"150","author":"Novick","year":"1990","journal-title":"Arch Intern Med"},{"key":"R33-7-20210131","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00002030-199402000-00010","article-title":"HIV seroconversion in intravenous-drug-users in San-Francisco, 1985-1990.","volume":"8","author":"Moss","year":"1994","journal-title":"AIDS"},{"key":"R34-7-20210131","first-page":"215","article-title":"Methadone treatment as a determinant of HIV risk reduction among injecting drug-users-a nested case-control study.","volume":"6","author":"Serpelloni","year":"1994","journal-title":"AIDS Care-Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"key":"R35-7-20210131","first-page":"97","article-title":"Drug abuse treatment as AIDS prevention.","volume":"113","author":"Metzger","year":"1999","journal-title":"Public Health"},{"key":"R36-7-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jurban\/jtg083","article-title":"HIV prevention among injection drug users: the need for integrated models.","volume":"80","author":"Metzger","year":"2003","journal-title":"J of Urban Health"},{"key":"R37-7-20210131","doi-asserted-by":"crossref","first-page":"S451","DOI":"10.1086\/377548","article-title":"Human immunodeficiency virus prevention and the potential of drug abuse treatment.","volume":"37","author":"Metzger","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R38-7-20210131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0376-8716(99)00104-0","article-title":"Drug abuse treatment as an HIV prevention strategy: a review.","volume":"59","author":"Sorensen","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"R39-7-20210131","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.drugpo.2005.02.008","article-title":"Effectiveness of drug dependence treatment in HIV prevention.","volume":"16","author":"Farrell","year":"2005","journal-title":"Int J Drug Policy"},{"key":"R40-7-20210131","first-page":"CD004145","article-title":"Substitution treatment of injecting opioid users for prevention of HIV infection.","volume":"2","author":"Gowing","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R41-7-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1258\/ijsa.2008.008362","article-title":"Systematic review of HIV and HCV infection among drug users in China.","volume":"20","author":"Bao","year":"2009","journal-title":"Int J STD AIDS"},{"key":"R42-7-20210131","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-7517-7-4","article-title":"The Chinese governments response to drug use and HIV\/AIDS: A review of policies and programs.","volume":"7","author":"Li J HT, Zhang","year":"2010","journal-title":"Harm Reduction Journal"},{"key":"R43-7-20210131","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.","volume":"355","author":"Fiellin","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"R44-7-20210131","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0376-8716(03)00061-9","article-title":"Safety and health policy considerations related to the use of buprenorphine\/naloxone as an office-based treatment for opiate dependence.","volume":"70","author":"Bridge","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R45-7-20210131","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1086\/432888","article-title":"Buprenorphine: Its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.","volume":"41","author":"Sullivan","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R46-7-20210131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1360-0443.2004.00963.x","article-title":"Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.","volume":"100","author":"Sullivan","year":"2005","journal-title":"Addiction"},{"key":"R47-7-20210131","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsat.2007.08.004","article-title":"Buprenorphine\/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.","volume":"35","author":"Sullivan","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"R48-7-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAI.0b013e3181d916db","article-title":"HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA Clinical Trials Network Multisite Study.","volume":"55","author":"Meade","year":"2010","journal-title":"J Acquir Immune Defic Synd"},{"key":"R49-7-20210131","first-page":"S247","article-title":"Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care.","volume":"43","author":"Schackman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R50-7-20210131","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0376-8716(03)00169-8","article-title":"Buprenorphine versus methadone maintenance: a cost-effectiveness analysis.","volume":"71","author":"Doran","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R51-7-20210131","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0140-6736(08)60954-X","article-title":"Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.","volume":"371","author":"Schottenfeld","year":"2008","journal-title":"Lancet"},{"key":"R52-7-20210131","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jsat.2006.05.005","article-title":"Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St Petersburg, Russia.","volume":"31","author":"Krupitsky","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"R53-7-20210131","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2471\/BLT.09.067330","article-title":"Preventing HIV transmission with antiretrovirals.","volume":"87","author":"De Cock","year":"2009","journal-title":"Bull World Health Organ"},{"key":"R54-7-20210131","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1086\/651485","article-title":"Addressing research priorities for prevention of HIV infection in the United States.","volume":"50","author":"Vermund","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R55-7-20210131","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1086\/651478","article-title":"Treatment to prevent transmission of HIV-1.","volume":"50","author":"Cohen","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R56-7-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/588673","article-title":"Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.","volume":"198","author":"Lima","year":"2008","journal-title":"J Infect Dis"},{"key":"R57-7-20210131","first-page":"655","article-title":"HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.","volume":"21","author":"Chander","year":"2009","journal-title":"AIDS Care-Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"key":"R58-7-20210131","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2009.08.003","article-title":"Social and structural determinants of HAART access and adherence among injection drug users.","volume":"21","author":"Krusi","year":"2010","journal-title":"Int J Drug Policy"},{"key":"R59-7-20210131","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","article-title":"Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.","volume":"105","author":"Uhlmann","year":"2010","journal-title":"Addiction"},{"key":"R60-7-20210131","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1086\/503905","article-title":"Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.","volume":"42","author":"Lucas","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R61-7-20210131","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/aje\/kwj059","article-title":"Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.","volume":"163","author":"Lucas","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R62-7-20210131","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1360-0443.2008.02323.x","article-title":"The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.","volume":"103","author":"Roux","year":"2008","journal-title":"Addiction"},{"key":"R63-7-20210131","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/630209","article-title":"Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.","volume":"49","author":"Roux","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R64-7-20210131","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.drugpo.2006.12.014","article-title":"Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).","volume":"18","author":"Spire","year":"2007","journal-title":"Int J Drug Policy"},{"key":"R65-7-20210131","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/00952990903108256","article-title":"Substance use and high risk sexual behaviors among women in psychosocial outpatient and methadone maintenance treatment programs.","volume":"35","author":"Tross","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R66-7-20210131","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/OLQ.0b013e3181ad54a3","article-title":"Methamphetamine use and other club drug use differ in relation to HIV status and risk behavior among gay and bisexual men.","volume":"36","author":"Rudy","year":"2009","journal-title":"Sex Transmit Dis"},{"key":"R67-7-20210131","first-page":"CD007192","article-title":"Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users.","volume":"1","author":"Meader","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R68-7-20210131","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/QAI.0b013e31817efb6e","article-title":"Effectiveness of HIV\/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA clinical trials network trial.","volume":"48","author":"Tross","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R69-7-20210131","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jsat.2008.11.008","article-title":"Motivational and skills training HIV\/sexually transmitted infection sexual risk reduction groups for men.","volume":"37","author":"Calsyn","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"R70-7-20210131","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1360-0443.2009.02812.x","article-title":"Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment.","volume":"105","author":"Calsyn","year":"2010","journal-title":"Addiction"},{"key":"R71-7-20210131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2004.10.004","article-title":"Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.","volume":"78","author":"Shoptaw","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"R72-7-20210131","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsat.2007.11.004","article-title":"Outcomes using two tailored behavioral treatments for substance abuse in urban gay and bisexual men.","volume":"35","author":"Shoptaw","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"R73-7-20210131","first-page":"1291","article-title":"HIV infection among injection-drug users-34 states, 2004-2007.","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R74-7-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","article-title":"Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.","volume":"373","author":"Granich","year":"2009","journal-title":"Lancet"},{"key":"R75-7-20210131","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jsat.2005.09.002","article-title":"Outpatient substance abuse treatment and HIVprevention: an update.","volume":"30","author":"Pollack","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"R76-7-20210131","first-page":"1238","article-title":"Availability of HIV-related health services in adolescent substance abuse treatment programs.","volume":"21","author":"Knudsen","year":"2009","journal-title":"AIDS Care-Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"key":"R77-7-20210131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugalcdep.2006.09.019","article-title":"Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.","volume":"88","author":"Sorensen","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"R78-7-20210131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.drugalcdep.2008.09.017","article-title":"Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV.","volume":"100","author":"Barnett","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R79-7-20210131","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201012011-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:36:08Z","timestamp":1786041368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201012011-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,1]]},"references-count":78,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181f9c10b","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,1]]}}}